Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
64,220,640
-
Share change
-
-3,340,226
-
Total reported value
-
$251,057,006
-
Put/Call ratio
-
97%
-
Price per share
-
$3.91
-
Number of holders
-
142
-
Value change
-
-$16,470,224
-
Number of buys
-
73
-
Number of sells
-
55
Institutional Holders of BIODELIVERY SCIENCES INTL IN - COM (BDSI) as of Q1 2021
As of 31 Mar 2021,
BIODELIVERY SCIENCES INTL IN - COM (BDSI) was held by
142 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
64,220,640 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BlackRock Inc., WASATCH ADVISORS INC, VANGUARD GROUP INC, SYSTEMATIC FINANCIAL MANAGEMENT LP, GOLDMAN SACHS GROUP INC, HealthInvest Partners AB, STATE STREET CORP, ROYCE & ASSOCIATES LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
142
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.